HILAQ: A Novel Strategy for Newly Synthesized Protein Quantification
Ma, Y.; McClatchy, D.B.; Barkallah, S.; et al.
The non-canonical amino acid azidohomoalanine (AHA) has proven effective at measuring the synthesis and turnover of newly synthesized proteins (NSPs) in various biological samples, such as mouse tissue. Described here by Yates et al. is a new metabolic labeling method - termed HILAQ (heavy isotope labeled azidohomoalanine quantification) – for enriching and quantifying NSPs in HEK293T and HT22 cell lines. Experimentally, cells are pulse labeled with light or heavy AHA then mixed (1:1 w/w) and processed by bottom-up LC-MS. Using peptide AHA enrichment as opposed to protein AHA enrichment (as in the QuaNCAT protocol) was found to yield enhanced NSP quantification for improved monitoring of protein dynamics.
Articles
- HILAQ: A Novel Strategy for Newly Synthesized Protein Quantification
- Multiplexed MRM-Based Protein Quantitation Using Two Different Stable Isotope-Labeled Peptide Isotopologues for Calibration
- Anion-Exchange Chromatography Coupled to High Resolution Mass Spectrometry: a Powerful Tool for Merging Targeted and Non-Targeted Metabolomics
- Metabolite Spectral Accuracy on Orbitraps
- How Close Are We to Complete Annotation of Metabolomes?
- Plasmonic Silver Nanoshells for Drug and Metabolite Detection
